Am J Respir Crit Care Med [PDF]
CC999999/Intramural CDC HHS/United States2018-04-04T00:00:00Z25876201PMC5884099vault ...
core
Background Bedaquiline fumarate (BDQ) is an anti-tubercular Biopharmaceutics Classification System (BCS class-II) drug & it has very less solubility.
Shital D. Godse +4 more
doaj +1 more source
Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations
Minhui Hu,1 Chunlan Zheng,1 Feng Gao2 1Department of Internal Medicine – Section 5, Wuhan Pulmonary Hospital (Wuhan Tuberculosis Control Institute), 2Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of ...
Hu MH, Zheng CL, Gao F
doaj
Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries [PDF]
core +1 more source
Transmission of bedaquiline-resistant Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. [PDF]
Sobol R +16 more
europepmc +1 more source
Diagnosis and Therapeutic Challenges of Drug-Resistant Tuberculosis Infection After Kidney Transplantation: A Rare Case Report. [PDF]
Song C +8 more
europepmc +1 more source
The Peak Plasma Concentration (Cmax)/Minimum Inhibitory Concentration (MIC) of bedaquiline and levofloxacin with special attention to the sputum conversion in the treatment of multidrug-resistant tuberculosis in Indonesia. [PDF]
Mariana N +10 more
europepmc +1 more source
Drug-Resistant Tuberculous Meningitis (DR-TBM) in a Low-Incidence Setting: Two Cases and an Evidence Review Highlighting Key Advances and Knowledge Gaps in Clinical Management. [PDF]
Boschung KF +7 more
europepmc +1 more source
Recent advances in tuberculosis treatment: Towards shorter, safer, and more effective therapies. [PDF]
Timboe K, Jackson JB, Becker GL.
europepmc +1 more source

